Other
Income taxes payable – long-term
Eli Lilly Income taxes payable – long-term decreased by 10.0% to $5.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $5.37B to $5.29B. Over 5 years (FY 2020 to FY 2025), Income taxes payable – long-term shows an upward trend with a 8.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase may indicate deferred tax liabilities growing due to timing differences, while a decrease suggests the settlement of long-term tax obligations.
Detailed definition
This represents the portion of income tax liabilities that are expected to be settled beyond the next twelve months. It...
Peer comparison
Commonly found in most capital-intensive firms with complex global tax structures.
Metric ID:
other_accrued_income_taxes_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.74B | $3.77B | $3.92B | $3.98B | $3.56B | $3.64B | $3.71B | $3.84B | $3.33B | $3.47B | $3.85B | $4.19B | $3.50B | $3.88B | $4.06B | $5.37B | $5.68B | $6.29B | $5.88B | $5.29B |
| QoQ Change | — | +0.8% | +4.0% | +1.5% | -10.6% | +2.4% | +1.9% | +3.6% | -13.3% | +4.1% | +11.0% | +8.8% | -16.5% | +10.9% | +4.7% | +32.2% | +5.8% | +10.7% | -6.7% | -10.0% |
| YoY Change | — | — | — | — | -4.8% | -3.4% | -5.4% | -3.4% | -6.4% | -4.8% | +3.8% | +9.0% | +5.0% | +11.8% | +5.5% | +28.2% | +62.6% | +62.3% | +44.7% | -1.5% |
Range$3.33B – $6.29B
CAGR+7.6%
Avg YoY Growth+12.7%
Median YoY Growth+4.4%
Current Streak2 quarters decline
Income taxes payable – long-term at Other Companies
Frequently Asked Questions
- What is Eli Lilly's income taxes payable – long-term?
- Eli Lilly (LLY) reported income taxes payable – long-term of $5.29B in Q1 2026.
- How has Eli Lilly's income taxes payable – long-term changed year-over-year?
- Eli Lilly's income taxes payable – long-term decreased by 1.5% year-over-year, from $5.37B to $5.29B.
- What is the long-term trend for Eli Lilly's income taxes payable – long-term?
- Over 5 years (2020 to 2025), Eli Lilly's income taxes payable – long-term has grown at a 8.9% compound annual growth rate (CAGR), from $3.84B to $5.88B.
- What does income taxes payable – long-term mean?
- Long-term income tax obligations that are not due within the next year.